PPT-April 2020 How to follow up patients with chronic liver diseases during the COVID-19

WGO COVID19 April 2020 Prof Mario Reis AlvaresdaSilva Associate Professor of Hepatology Universidade Federal do Rio Grande do Sul Head GI Liver Division Hospital de Clínicas de Porto Alegre. COVID-19: Make it the Last Pandemic by The Independent Panel for Pandemic Preparedness & Response2 of 86 Disclaimer: The designations employed and the presentation of the material in this publication 31302928272625242322232129312928273126252625242322312625262531303130292827292625242322212024191829172322272916152414rf11n29tb29767530294r2425329303052730622731311129313029282726252724232229212028COVID 24Themoststrategicallyusefulpublichealthmeasureinsuchcircumstancesistox0066006Cattenthecurveofthediseasethatisreducethespeedatwhich the virus is spread from human to human so that the naturally occurr Prof . Giacomo Grasselli. Associate Professor of . Anesthesiology. and Intensive Care . Medicine. , Dept of . Pathophysiology. and Transplantation, . University. of Milan. Medical. . Director. What will change?. Nancy . Reau. , MD. Chief, Section of Hepatology . Richard B. Capps Chair of Hepatology. Rush University Medical Center. Prioritization of patient care in CLD. Decompensated Cirrhosis and Pre-Transplant. ADVANCES IN HEPATOLOGYSection Editor: Eugene R. Schiff, MDCurrent Developments in the Treatment of Hepatitis and Hepatobiliary Disease What are the typical presenting How may the liver be involved? Mo – Dialysis and Labour Room. Dr Raman Sardana. Secretary, Hospital Infection Society – India . Head, Microbiology and Infection Prevention and Control, Indraprastha Apollo. Overview. Special Services have their own challenges and need special focus. Gamal. . Esmat. (Egypt). Treatment considerations for COVID-19 in patients with chronic liver disease or after liver transplantation. Currently no drugs approved for CoVID-19, several tested, many under investigation.. Kelly W. Burak, MD, FRCPC, MSc (Epid). Professor, Departments of Medicine & Oncology. University of Calgary, Calgary, AB, Canada. LIVER CO-MORBIDITIES AND COVID-19. Autoimmune Hepatitis. Diagnosis during pandemic. A Global Outlook. Jeffrey Frankel. James W. . Harpel. Professor of Capital Formation and Growth. Dean’s Council, October 9, 2020. Part I: Differences Across Countries. Health & economic impacts of the pandemic have spread . Menso. Westerouen van . Meeteren. and Joost PH . Drenth. . Radboud. UMC. , Nijmegen, The Netherlands . LIVER CO-MORBIDITIES AND COVID-19. Content. MAFLD and risk of . SARS-CoV-2. . transmission. Distribution of respondents by gender . Who responded to the survey? . Distribution of respondents by age. 970 people. People living with pain for 10 years or longer were most represented. 7 Languages:. The eyecare market experienced huge decreases when the pandemic started. According to a May 2020 survey/report from The Vision Council, monthly adult eye exams declined from 10 million during February to 2 million during April. . Natalie Marlowe. 1. , David Lam. 2. , Suthat Liangpunsakul. 3. . ConclusionS. We documented a significant increase in AH hospitalizations, in-hospital mortality, and healthcare cost and utilization among AH patients, notably in those who were...